KATHERINE WITTMER: Open Payments
NPI 1164164679 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,584 in 187 payments from 23 companies in 2025. Trend: 2023 $162 · 2024 $1,271 · 2025 $3,584
Food & beverage: $3,575Education: $9
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 44 | $818 |
| Janssen Biotech, Inc. | 23 | $572 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 24 | $314 |
| GENZYME CORPORATION | 11 | $282 |
| Ardelyx, Inc. | 12 | $258 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $174 |
| PFIZER INC. | 11 | $168 |
| Gilead Sciences, Inc. | 7 | $158 |
| QOL Medical, LLC | 6 | $158 |
| Ipsen Biopharmaceuticals, Inc | 11 | $142 |
Products named: TREMFYA, RINVOQ, DUPIXENT, XIFAXAN, IBSRELA, Sucraid, SKYRIZI, CREON.
Industry payments across KY — which companies pay providers there.
